Skip to content

Value & Innovation

Value & Innovation
STAT

In reversal, FDA advisers vote to support approval of Amylyx’s drug for ALS

Article
Value & Innovation
Brookings

How three big bills in Congress will spur innovation and competitiveness

Podcast/Article
Value & Innovation
Drug Channels Institute

Specialty Drugs Update: Trends, Controversies, and Outlook

Webinar
Value & Innovation
Tufts Cost-Effectiveness Analysis Registry

When are breakthrough therapies cost-effective?

Published Paper
Value & Innovation
The Pew Charitable Trusts 

3D Printing Can Strengthen America’s Medical Supply Chain

Article
Value & Innovation
AEI

Price Controls on Medicines Save Money for the Federal Government, but Not Necessarily for Consumers

Blog